<DOC>
	<DOCNO>NCT02654314</DOCNO>
	<brief_summary>A double blind randomize control trial investigate melatonin , 5mg , compare placebo , give patient least 65 year old , admit hospital general medical floor , prevent delirium .</brief_summary>
	<brief_title>Prevention Delirium Inpatients Utilizing Melatonin</brief_title>
	<detailed_description>This study randomize double blind control trial , design evaluate efficacy melatonin decrease incidence delirium elderly hospitalize adult compare placebo capsule . The study conduct two general Internal Medicine inpatient floor Yale-New Haven Hospital , St. Raphael 's campus . Within 24 hour admission , study subject approach member research team , ask informed consent . Patients consent participate randomize either treatment placebo arm . Each subject administer capsule contain either placebo 5 mg melatonin even 9 p.m . The capsule prepare administer Yale-New Hospital Investigational Drug Service . The capsule administer nightly discharge maximum 2 week , hospitalization prolong . Subjects assess twice daily floor nurse evidence delirium use CAM ( Confusion Assessment Method ) , validate clinical tool identify delirium , current standard practice tool diagnosis delirium .</detailed_description>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>Inpatient admission general internal medicine service expect lifespan length stay â‰¤ 48 hour NonEnglish speak Already take melatonin time randomization Presence delirium time randomization Unable take oral medication Subject proxy unable provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>prevention ; delirium ; in-patients ; melatonin ,</keyword>
</DOC>